2016
DOI: 10.1080/08923973.2016.1233426
|View full text |Cite
|
Sign up to set email alerts
|

The increasingly anti-tumor effect of a colonic carcinoma DNA vaccine carrying HER2 by the adjuvanticity of IL-12

Abstract: The present study aimed to determine the effect of recombinant DNA vaccine-based human epidermal growth factor receptor-2 (HER2) and Interleukin 12 (IL-12) on the development of colonic carcinoma in mice and the potential immune mechanisms involved. Recombinant plasmids pVAX1-HER2, pVAX1-IL-12 and pVAX1-HER2-IL-12 were constructed, and injected into female mice intramuscularly (i.m.) followed by an electric pulse. The humoral and cellular immune responses after immunization were examined by enzyme linked immun… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 14 publications
0
1
0
Order By: Relevance
“…It has been demonstrated that H19 lncRNA binds and sequesters let-7, which inhibits its function (12). In addition, Gao et al (13) identified that let-7c is negatively associated with human epidermal growth factor receptor 2 (HER2) expression. The results of these studies suggest that a correlation and potential crosstalk between H19, let-7c and HER2 may exist.…”
Section: Introductionmentioning
confidence: 99%
“…It has been demonstrated that H19 lncRNA binds and sequesters let-7, which inhibits its function (12). In addition, Gao et al (13) identified that let-7c is negatively associated with human epidermal growth factor receptor 2 (HER2) expression. The results of these studies suggest that a correlation and potential crosstalk between H19, let-7c and HER2 may exist.…”
Section: Introductionmentioning
confidence: 99%